COMMUNIQUÉS West-GlobeNewswire

electroCore Files Registration Statement on Form S-3
15/07/2019
BASKING RIDGE, N.J., July 15, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that it has filed a "universal shelf" registration statement on [...]
Eyenovia, Inc. Announces Closing of Public Offering
15/07/2019
NEW YORK, July 15, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented piezo-print [...]
Conformis Establishes Alliance to Focus on ASC Joint Replacement
15/07/2019
BILLERICA, Mass., July 15, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell [...]
Cancer Genetics, Inc. Announces Strategic Transactions
15/07/2019
Sale of BioPharma business to Interpace Diagnostics Group, Inc. Clinical services business acquired by siParadigm Diagnostic Informatics Significantly reduces its debt burden and will continue to operate its Discovery [...]
Intuitive Surgical acquires Schölly Fiberoptic’s robotic endoscope business
15/07/2019
SUNNYVALE, Calif. and DENZLINGEN, Germany, July 15, 2019 (GLOBE NEWSWIRE) -- Intuitive (Nasdaq: ISRG), the pioneer and a global leader in robotic-assisted, minimally invasive surgery and manufacturer of da Vinci [...]
Arbutus Announces Preliminary Phase 1a/1b Clinical Trial Results for AB-506, an Oral Capsid Inhibitor in Development for People with Chronic Hepatitis B
15/07/2019
Results demonstrate that AB-506 is a potent capsid inhibitor Phase 1a/1b clinical trial to continue with the enrollment of further cohorts Conference call and webcast scheduled today at 4:45 pm ET WARMINSTER, Pa., July [...]
Repligen Corporation Announces Proposed Public Offerings of $100 million of Common Stock and $250 million of Convertible Senior Notes
15/07/2019
WALTHAM, Mass., July 15, 2019 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN) (“Repligen”) today announced that it has commenced concurrent underwritten public offerings of $100,000,000 in shares of its common [...]
Artelo Biosciences Reports Third Quarter 2019 Financial Results and Provides Corporate Update
15/07/2019
LA JOLLA, Calif., July 15, 2019 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL) , a clinical stage biopharmaceutical company focused on the development of therapeutics that modulate the endocannabinoid [...]
Homology Medicines Appoints Alise Reicin, M.D., to the Board of Directors
15/07/2019
- Celgene Executive with Early- and Late-Stage Global Clinical Development Experience Joins as Homology Advances Lead Gene Therapy Program for PKU Through the Clinic - BEDFORD, Mass., July 15, 2019 (GLOBE NEWSWIRE) -- [...]
Adverum Biotechnologies Appoints Senior Leaders
15/07/2019
Carol Hoang, Pharm.D, MBA Joins as Vice President, Medical Affairs and James Shahbazian Joins as Vice President, Finance MENLO PARK, Calif., July 15, 2019 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM [...]
Driven Deliveries Completes Acquisition of Mountain High Recreation, Increases Forecasted Consumer Revenue to $10 Million
15/07/2019
SAN DIEGO, July 15, 2019 (GLOBE NEWSWIRE) -- Driven, the online cannabis sales platform, marketing and home delivery leader announced today that it has completed the acquisition of Mountain High Recreation, the [...]
CROSSJECT : information relative au nombre total de droits de vote et d'actions composant le capital social
15/07/2019
Communiqué de Presse Information relative au nombre total de droits de vote et d’actions composant le capital social Dijon, le 15 juillet 2019 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui [...]
Transactions in relation to share buyback program
15/07/2019
Announcement no. 42/2019 15 July 2019 Transactions in relation to share buyback program On 14 May 2019, Össur hf. initiated a share buy-back program, see Company announcement no. 31/2019. The purpose of the share [...]
Conformis to Host Second Quarter 2019 Financial Results Webcast on July 31, 2019
15/07/2019
BILLERICA, Mass., July 15, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will host a webcast on Wednesday, July 31, 2019, at 4:30 p.m. Eastern Time to discuss its financial results for [...]
Segra Receives Licence for Portland Hemp Tissue Culture Facility
15/07/2019
VANCOUVER, British Columbia, July 15, 2019 (GLOBE NEWSWIRE) -- Segra International Corp. (“ Segra ” or the “ Company ”) an agriculture technology company, is pleased to announce that it has received its Industrial Hemp [...]
LI SURGEON TO TAKE ON ROLE OF ASSOCIATE DIRECTOR OF NUMC BURN CENTER
15/07/2019
Garden City, NY, July 15, 2019 (GLOBE NEWSWIRE) -- Today, serious burns are among the most life threatening and hard to treat medical emergencies in the world. Nassau University Medical Center (NUMC) Burn Center is [...]
Seelos Therapeutics Announces Receipt of a Grant for Funding of SLS-005 Program
15/07/2019
Team Sanfilippo Foundation to Provide Funding for Planned FDA/EMA Open-Label Phase IIb/III and Expanded Access Study in Sanfilippo Syndrome Initial Patient Dosing is Scheduled to Begin in Q3 2019 NEW YORK, July 15, 2019 [...]
BioSig Technologies, Inc. to Receive 15 Units of PURE EP™ System from Manufacturer for Commercial Installation - Corrected Version
15/07/2019
Westport, CT, July 15, 2019 (GLOBE NEWSWIRE) -- 1) N ew units to be prepped for next phase of targeted commercial launch strategy 2) Company includes 3 additional hospitals to its list of medical institutions for [...]
NeuBase Therapeutics Initiates Trading on NASDAQ Under Ticker Symbol “NBSE”
15/07/2019
PITTSBURGH, July 15, 2019 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“NeuBase” and the “Company”), a biotechnology company developing next generation antisense therapies to address genetic diseases, [...]

Pages